✦ LIBER ✦
First Bacterial Infection as an Alternative Clinical End Point for Regulatory Approval of Agents Targeting the Primary Cystic Fibrosis Defect
✍ Scribed by Donald R. VanDevanter
- Book ID
- 116683511
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 76 KB
- Volume
- 147
- Category
- Article
- ISSN
- 1097-6833
No coin nor oath required. For personal study only.